文献速递神经康复

低成本虚拟现实用于慢性卒中上肢治疗:一项随机临床试验

Use of low-cost virtual reality in the treatment of the upper extremity in chronic stroke: a randomized clinical trial.
PubMed 文献 · J Neuroeng Rehabil · 2024-01-22

该随机临床试验纳入36例慢性卒中患者,比较常规治疗与常规治疗联合Leap Motion Controller®虚拟现实方案对上肢功能的影响。组间分析除Action Research Arm Test的D子项外无显著差异,实验组在所有长期变量上均达显著改善,满意度和依从性很高。

要点

  • Leap Motion Controller®作为辅助工具可改善慢性卒中患者握力、灵活性和运动功能。
  • 组间比较除ARAT的D子项外无显著差异,实验组长期变量均显著改善。
  • 设备被感知为安全、有动机且易用,满意度和依从性很高。

核心结论

  • Leap Motion Controller®系统作为辅助工具可改善慢性卒中患者的握力、灵活性和运动功能。
  • 该设备被感知为安全、有动机且易用。

研究设计与样本

  • 随机临床试验,纳入36例慢性卒中患者,随机分为常规治疗对照组和虚拟现实协议联合常规治疗实验组。
  • 结局指标包括握力、Block and Box Test、Action Research Arm Test、Disabilities of the Arm, Shoulder and Hand、技术满意度问卷和治疗依从性。

主要发现

  • 组间统计分析除Action Research Arm Test的D子项外无显著差异。
  • 组内分析显示两组均有显著差异,但实验组在所有长期变量上均达显著。
  • 满意度和依从性水平很高。

临床怎么用

  • 可将Leap Motion Controller®作为常规治疗的辅助工具用于慢性卒中上肢康复。
  • 该设备安全、有动机且易用,适合在慢性卒中患者中推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronicity and lack of motivation often go together during the upper limb rehabilitation process in stroke. Virtual reality is a useful tool in this context, providing safe, intensive, individualised treatments in a playful environment. B-cost, easy-to-use devices with personalised and motivating games for a specific population seem to be the most effective option in the treatment of the upper limbs. METHODS: A randomised clinical study with follow-up was carried out to assess the effectiveness of the Leap Motion Controller® device in improving the functionality of the upper limb in patients with chronic stroke. Patients (n = 36) were randomised into a control group that performed conventional therapy and an experimental group that combined the virtual reality protocol with conventional therapy. The outcome measures used were grip strength; the Block and Box Test; the Action Research Arm Test; the Disabilities of the Arm, Shoulder and Hand; as well as a Technology Satisfaction Questionnaire and adherence to treatment. RESULTS: Inter-group statistical analysis showed no significant differences except in subsection D of the Action Research Arm Test. Intra-group analysis showed significant differences in both groups, but the experimental group reached significance in all long-term variables. Satisfaction and adherence levels were very high. CONCLUSIONS: The Leap Motion Controller® system, as a complementary tool, produces improvements in grip strength, dexterity and motor function in patients with chronic stroke. It is perceived as a safe, motivating, and easy-to-use device. CLINICAL REGISTRATION: NCT04166617 Clinical Trials.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Aguilera-Rubio Á, Alguacil-Diego IM, Mallo-López A, et al. Use of low-cost virtual reality in the treatment of the upper extremity in chronic stroke: a randomized clinical trial. J Neuroeng Rehabil. 2024. PMID: 38254147. doi:10.1186/s12984-024-01303-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。